The pact would entail the Indian company receiving up to $38 million (over Rs 165 crore).
Chhaya Ranka trusts her grandma's kitchen to sort her out every single time.
Along with medication, following a healthy diet along with regular exercise can help you fight the hormonal disorder, suggests gynecologist, obstetrician and IVF expert Dr Amit Patil.
A dark chocolate face mask can give you the softest skin in the world.
Dermatologist Dr Parul Kolhe says there are a few beauty treatments that are best left to the professionals. Here's why you shouldn't try them at home.
While Ranbaxy tested the lot in question and found it to have met the specified standards, it is recalling the product on the US health regulator Food and Drug Administration's recommendation, the company said.
Rediff reader Heera Nawaz, 59 from Bengaluru writes a letter to her 15-year-old self.
Dr Dinesh Jain shares some valuable tips.
Tackle your hair and skin problems with expert help from Dr Dinesh Jain.
'The Ek Do Teen star struggled with a problem skin all through her reign as numero uno.' 'And yet acne never got into the way of her incredible success.' All this and more in Sukanya Verma's Super Filmi Week.
Here's a fun way to find out how healthy is your skin
Wellness expert Roopashree Sharma answers your health queries.
Did you know that baby oil can help you get rid of mascara stains?
'Instead of fearing these foods, which never helps because it only increases cortisol levels, exercise control over your mouth, greed, portions and adopt an overall healthy lifestyle,' advises lifestyle coach Luke Coutinho.
Your skin has borne the brunt of all the partying you did last weekend. Now, it's time to bring the glow back.
Do you know tanning beds emit UVA rays and cause skin cancer?
Tackle your hair and skin problems with expert help from Dr Dinesh Jain.
Five face packs to keep your skin's healthy glow.
Wellness expert Roopashree Sharma tells you how you can use natural methods to improve your health.
Ranbaxy Laboratories on Monday said it has received the US Food and Drug Administration's approval to manufacture and market Isotretinoin capsules, a generic version of Hoffman LaRoche's Accutane.
India's top drug maker Ranbaxy Laboratories said on Tuesday its first-quarter net profit nearly tripled on booming exports of generic drugs to the United States.
The new entrants are young, enterprising Chinese men and women who want to tap into the promising Indian market.
The proposed merger would likely harm future competition
CBD oil, found in marijuana, is gaining popularity for its pain-relieving properties. It's now legally available in India
Here are tips on how to manage your skin this summer.
Feeling good is an integral part of looking good.
Singer, fashion icon and former model says Indians should stop obsessing over fair skin and start being proud of their natural skin tone.
High humidity causes sweat, dirt and dust along with other toxins to build up on the surface of the skin. Dr Saumya Shetty Hegde tells you how to take care.
Sun Pharma and Dr Reddy's top list in terms of those who face most class-action litigation
Indian fashion, mostly, has been either inexpensive streetwear or wedding wear lacking elegance Varana brings. Kishore Singh drops by the brand's flagship store on London's iconic Dover Street.
Pharma major Ranbaxy Laboratories has set aside Rs 257.4 crore (Rs 2.57 billion) towards the financial impact of a US ban on import of products made at its plant at Toansa.
Did you know that turmeric can help prevent cancer? That garlic can cure toothaches?
Yoga instructor and meditation expert Paloma Gangopadhyay shows you how to get started with yoga at home.
'Trust me, it's a disadvantage because people don't take you seriously.'
Ranbaxy was asked to sell all products containing Leuprorelin which are marketed and supplied under brand name Eligard.
Routine practise will help regularise hormonal activity within the body says yoga Grand Master Akshar.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances